Garden State Ambulatory Cr Center is categorized under Ophthalmologists in Toms River, NJ .
Garden State Ambulatory Cr Center was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Ophthalmologists business, which does work in the B2C market, and is classified as a Ophthalmologists, under code number 6214981 by the NAICS.
If you are seeking more information, feel free to contact Moshe Rothkopf at the company’s single location by writing to 1 Plaza Drive, Toms River, New Jersey NJ 08757 or by phoning (732) 341-7010. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Garden State Ambulatory Cr Center |
Contact Person: | Moshe Rothkopf |
Address: | 1 Plaza Drive, Toms River, New Jersey 08757 |
Phone Number: | (732) 341-7010 |
Website Address: | ophthalmologygardenstateeye.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Ophthalmologists |
SIC Code: | 8011 |
NAICS Code: | 6214981 |
Share This Business: |
Garden State Ambulatory Cr Center was started in 0 to provide professional Ophthalmologists under the SIC code 8011 and NAICS code 6214981. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Moshe Rothkopf for inquiries that concern Garden State Ambulatory Cr Center by calling the company number (732) 341-7010, as your correspondence is most welcome. Additionally, the physical location of the single location of Garden State Ambulatory Cr Center can be found at the coordinates 39.97235,-74.24617 as well as the street address 1 Plaza Drive in Toms River, New Jersey 08757.
For its online presence, you may visit Garden State Ambulatory Cr Center’s website at ophthalmologygardenstateeye.com and engage with its social media outlets through on Twitter and on Facebook.